• 2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work
• 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases
• 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice
• A family with discordance between malignant hyperthermia susceptibility and rippling muscle disease
• A Mixed-Methods Systematic Review on Syndemics in Rheumatology
• A rippling muscle disease gene is localized to 1q41: evidence for multiple genes
• Acquired rippling muscle disease in association with myasthenia gravis
• Acquired rippling muscle disease with myasthenia gravis
• Aesthetic Limitations in Direct-to-Implant Prepectoral Breast Reconstruction
• Alterations of excitation-contraction coupling and excitation coupled Ca(2+) entry in human myotubes carrying CAV3 mutations linked to rippling muscle
• American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4
• American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5
• Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
• Autoimmune acquired rippling muscle disease and myasthenia gravis
• Barriers and facilitators for physical activity in rheumatic and musculoskeletal disease: a European-based survey
• Bedside diagnosis of rippling muscle disease
• Bedside diagnosis of rippling muscle disease in CAV3 p.A46T mutation carriers
• Breast reconstruction using tissue expanders and implants in Hodgkin's patients with prior mantle irradiation
• CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: Expanding the phenotypic spectrum of caveolinopathies
• Caveolin-3 gene mutation in Japanese with rippling muscle disease
• Caveolin-3 regulates myostatin signaling. Mini-review
• Caveolinopathies in Greece
• Caveolinopathies: from the biology of caveolin-3 to human diseases
• Characteristic findings of skeletal muscle MRI in caveolinopathies
• Characterization of the in vitro expressed autoimmune rippling muscle disease immunogenic domain of human titin encoded by TTN exons 248-249
• Cloning and chromosomal location of a novel member of the myotonic dystrophy family of protein kinases
• Coexistence of a CAV3 mutation and a DMD deletion in a family with complex muscular diseases
• Coping with rheumatic stressors (CORS) questionnaire: Spanish translation and cross-cultural adaptation
• Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group session
• Developing a framework for the implementation of recommendations for lifestyle factors for people with RMDs across Europe: assessment of current materials and implementation needs
• Developing an Outcome Measures in Rheumatology (OMERACT) Core set of Outcome Measures for FOot and ankle disorders in RheumaTic and musculoskeletal diseases (COMFORT): core domain set study protocol
• Differential effects of myopathy-associated caveolin-3 mutants on growth factor signaling
• Drug persistence in patients with rheumatic and musculoskeletal diseases during a major economic crisis: results from a nationwide cross-sectional online survey
• Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
• Electrically active immune-mediated rippling muscle disease preceding breast cancer
• EULAR 2021 updated viewpoints on SARS-CoV-2 vaccination in patients with RMDs: a guidance to answer patients' questions
• EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs
• EULAR points to consider for the use of imaging to guide interventional procedures in patients with rheumatic and musculoskeletal diseases (RMDs)
• Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia
• Exploring discordance between Health Literacy Questionnaire scores of people with RMDs and assessment by treating health professionals
• Frequency and Pattern of Rheumatoid Arthritis in a Tertiary Hospital in Maiduguri, North-Eastern Nigeria
• Generation of two human iPSC lines (HIMRi002-A and HIMRi003-A) derived from Caveolinopathy patients with rippling muscle disease
• Heat therapy in rheumatic and musculoskeletal diseases - an overview of clinical and molecular effects
• High blood pressure prevalence, awareness, treatment, and blood pressure control among Ugandans with rheumatic and musculoskeletal disorders
• Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults
• Identification of skeletal muscle autoantigens by expression library screening using sera from autoimmune rippling muscle disease (ARMD) patients
• Immune-mediated rippling muscle disease and myasthenia gravis
• Immune-Mediated Rippling Muscle Disease Associated With Thymoma and Anti-MURC/Cavin-4 Autoantibodies
• Immune-mediated rippling muscle disease in a patient with treated hypothyroidism
• Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two
• Immune-mediated rippling muscle disease: not your usual muscle twitches and ache
• Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis
• Impact of COVID-19 on disease (self) management and well-being in people with Rheumatic or Musculoskeletal diseases across four European countries: a mixed methods study
• Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies
• Living with foot and ankle disorders in rheumatic and musculoskeletal diseases: A systematic review of qualitative studies to inform the work of the OMERACT Foot and Ankle Working Group
• Longitudinal and transversal propagation of excitation along the tubular system of rat fast-twitch muscle fibres studied by high speed confocal microscopy
• Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies
• Multimorbidity in rheumatoid arthritis: common mechanistic links and impact and challenges in routine clinical practice
• Myosin Rod Hypophosphorylation and CB Kinetics in Papillary Muscles from a TnC-A8V KI Mouse Model
• Myotonia associated with caveolin-3 mutation
• NET-RMDs study: networks of fatigue and pain in rheumatic and musculoskeletal diseases - protocol for an international cross-sectional study
• Neuromuscular hyperexcitability syndromes
• Neuromyotonia with neuropathy and muscle hypertrophy: association or cause?
• Novel PTRF mutation in a child with mild myopathy and very mild congenital lipodystrophy
• Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review
• Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status
• Our Experience Using Round Nano-Surface Ergonomix Implants for Breast Reconstruction: A Single-Center Retrospective Study
• Phenotypic variability in rippling muscle disease
• Phenotypic variability in rippling muscle disease
• Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases
• Physical mapping of the rippling muscle disease locus
• Porcine acellular dermal matrix (strattice) in primary and revision cosmetic breast surgery
• Postoperative Complications Following Prepectoral Versus Partial Subpectoral Implant-Based Breast Reconstruction Using ADM: A Systematic Review and Meta-analysis
• Prevalence of undiagnosed rheumatic and musculoskeletal diseases and its association with health-related quality of life and with physical function
• Protocol for a systematic literature review of smartphone apps to support the self-management of rheumatic and musculoskeletal diseases: development strategies, theoretical underpinnings and barriers to engagement
• Re-thinking the perception of long-term opioid use in RMDs
• Rippling is not always electrically silent in rippling muscle disease
• Rippling muscle disease and facioscapulohumeral dystrophy-like phenotype in a patient carrying a heterozygous CAV3 T78M mutation and a D4Z4 partial deletion: Further evidence for "double trouble" overlapping syndromes
• Rippling muscle disease and intermittent esotropia
• Rippling Muscle Disease with Irregular Toe Jerks and Anti-acetylcholine Receptor Antibodies: Remission after Extended Thymectomy
• Rippling muscle disease with myasthenia gravis
• Rippling muscle disease: evidence for phenotypic and genetic heterogeneity
• Rippling muscle disease: variable phenotype in a family with five afflicted members
• Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
• SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis
• Self-diagnosis of a triple trouble
• Sporadic rippling muscle disease unmasked by simvastatin
• Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group
• Standardization of interstitial lung disease assessment by ultrasound: results from a Delphi process and web-reliability exercise by the OMERACT ultrasound working group
• Teaching Video NeuroImages: Rippling muscle disease with caveolin myopathy
• Textured saline-filled breast implants for augmentation mammaplasty: does overfilling prevent deflation? A long-term follow-up
• The biology of caveolae: lessons from caveolin knockout mice and implications for human disease
• The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study
• Trends for opioid prescribing and the impact of the COVID-19 pandemic in patients with rheumatic and musculoskeletal diseases between 2006 and 2021
• Trends in consultations and prescribing for rheumatic and musculoskeletal diseases: an electronic primary care records study
• Two novel CAV3 gene mutations in Japanese families
• Unilateral calf atrophy secondary to a de novo mutation of the caveolin-3 gene